Bloomberg Business writes about the $215 million project to be announced today.

EXCERPT

Precision medicine holds more promise because the cost of genomic sequencing has fallen dramatically, from hundreds of millions of dollars to about $1,000 per patient. The cheaper costs, in conjunction with advances in scientific understanding of the disease, has led drugmakers to pursue more personalized therapies for cancers and numerous genetic disorders.

The study across 1 million patients will differ from traditional research as the NIH seeks to engage patients and let them have access to their own data, Francis Collins, director of the NIH, said Thursday in a press conference.

SOURCE

http://www.bloomberg.com/news/articles/2015-01-30/obama-plans-215-million-precision-medicine-effort-to-find-cures